Search

everythinglearnresearchcommunity

for

Search:↓

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

Endothelial TLR2 is crucial for timely wound healing, but HFSC TLR2 is not needed.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

A child with Sweet syndrome was found to have chronic granulomatous disease and improved with treatment.

Alopecia areata is caused by the immune system attacking hair follicles.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Similar treatments might work for different types of scarring hair loss.

Chronic contact eczema may help hair regrowth in alopecia areata by reducing certain immune cell movement.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Lichen Planopilaris causes irreversible hair loss due to immune attacks on hair stem cells, but modulating PPAR-γ might help treat it.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

A combination of ciclosporin and ketoconazole can effectively treat severe hair loss in dogs.

Cyclosporine effectively treated a woman's stubborn skin condition.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.